MAPT and Alzheimer disease: Recent evidence supports that soluble Aβ oligomers are the primary pathogenic drivers of neurodegeneration in AD and further proposes that soluble Aβ oligomers cooperate with pathological Tau to progressively degenerate the learning and memory circuitry required for cognitive functions3.